Page 863 - Clinical Immunology_ Principles and Practice ( PDFDrive )

834 ParT SIX Systemic Immune Diseases

6. Feder HM, Salazar JC. A clinical review of 105 patients with PFAPA (a 21. de Koning HD, van Gijn ME, Stoffels M, et al. Myeloid lineage-restricted
periodic fever syndrome). Acta Paediatr 2010;99:178–84. somatic mosaicism of NLRP3 mutations in patients with variant
7. Schnitzler L. Lésions urticariennes chroniques permanentes (érythème Schnitzler syndrome. J Allergy Clin Immunol 2015;135:561–4.
pétaloïde ?) Cas cliniques, n° 46 B. J Dermatol d’Angers 1972. 21a. Harrison SR, McGonagle D, Nizam S, et al. Anakinra as a diagnostic
8. Mulders-Manders CM, Simon A. Hyper-IgD syndrome/mevalonate kinase challenge and treatment option for systemic autoinflammatory disorders
deficiency: what is new? Semin Immunopathol 2015;37:371–6. of undefined etiology. JCI Insight 2016;1(6):e86336.
9. Stoffels M, Szperl A, Simon A, et al. MEFV mutations affecting pyrin 22. van der Hilst J, Moutschen M, Messiaen P, et al. Efficacy of anti-IL-1
amino acid 577 cause autosomal dominant autoinflammatory disease. treatment in familial Mediterranean fever: a systematic review of the
Ann Rheum Dis 2014;73:455–61. literature. Biologics 2016;10:75–80.
10. Mandey SHL, Kuijk LM, Frenkel J, et al. A role for geranylgeranylation in 23. Butbul Aviel Y, Tatour S, Gershoni Baruch R, et al. Colchicine as a
interleukin-1 beta secretion. Arthritis Rheum 2006;54:3690–5. therapeutic option in periodic fever, aphthous stomatitis, pharyngitis,
11. Liao YH, Lin YC, Tsao ST, et al. HMG-CoA reductase inhibitors activate cervical adenitis (PFAPA) syndrome. Semin Arthritis Rheum
caspase-1 in human monocytes depending on ATP release and P2X7 2016;45:471–4.
activation. J Leukoc Biol 2013;93:289–99. 24. ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the
12. van der Burgh R, Pervolaraki K, Turkenburg M, et al. Unprenylated RhoA management of autoinflammatory diseases. Ann Rheum Dis
contributes to IL-1beta hypersecretion in mevalonate kinase deficiency 2015;74:1636–44.
model through stimulation of Rac1 activity. J Biol Chem 25. Bodar EJ, Kuijk LM, Drenth JP, et al. On-demand anakinra treatment is
2014;289:27757–65. effective in mevalonate kinase deficiency. Ann Rheum Dis
13. van der Burgh R, Nijhuis L, Pervolaraki K, et al. Defects in mitochondrial 2011;70:2155–8.
clearance predispose human monocytes to interleukin-1beta 26. Ter Haar N, Lachmann H, Ozen S, et al. Treatment of autoinflammatory
hypersecretion. J Biol Chem 2014;289:5000–12. diseases: results from the Eurofever Registry and a literature review. Ann
14. Tricarico PM, Kleiner G, Valencic E, et al. Block of the mevalonate Rheum Dis 2013;72:678–85.
pathway triggers oxidative and inflammatory molecular mechanisms 27. Burton MJ, Pollard AJ, Ramsden JD. Tonsillectomy for periodic fever,
modulated by exogenous isoprenoid compounds. Int J Mol Sci aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA).
2014;15:6843–56. Cochrane Database Syst Rev 2010;(9):CD008669.
15. Wurster VM, Carlucci JG, Feder HM Jr, et al. Long-term follow-up of 28. Arkwright PD, Abinun M, Cant AJ. Mevalonic aciduria cured by bone
children with periodic fever, aphthous stomatitis, pharyngitis, and marrow transplantation. N Engl J Med 2007;357:1350.
cervical adenitis syndrome. J Pediatr 2011;159:958–64. 29. Neven B, Valayannopoulos V, Quartier P, et al. Allogeneic bone marrow
16. Cochard M, Clet J, Le L, et al. PFAPA syndrome is not a sporadic disease. transplantation in mevalonic aciduria. New Engl J Med 2007;356:2700–3.
Rheumatology 2010;49:1984–7. 30. Chaudhury S, Hormaza L, Mohammad S, et al. Liver transplantation
17. Kolly L, Busso N, von Scheven-Gete A, et al. Periodic fever, aphthous followed by allogeneic hematopoietic stem cell transplantation for
stomatitis, pharyngitis, cervical adenitis syndrome is linked to atypical mevalonic aciduria. Am J Transplant 2012;12:1627–31.
dysregulated monocyte IL-1beta production. J Allergy Clin Immunol 31. van der Hilst JC. Recent insights into the pathogenesis of type AA
2013;131:1635–43. amyloidosis. ScientificWorldJournal 2011;11:641–50.
18. Sundqvist M, Wekell P, Osla V, et al. Increased intracellular oxygen radical 32. Lane T, Gillmore JD, Wechalekar AD, et al. Therapeutic blockade of
production in neutrophils during febrile episodes of periodic fever, interleukin-6 by tocilizumab in the management of AA amyloidosis and
aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. Arthritis chronic inflammatory disorders: a case series and review of the literature.
Rheum 2013;65:2971–83. Clin Exp Rheumatol 2015;33:S46–53.
19. de Koning HD, Bodar EJ, van der Meer JW, et al. Schnitzler syndrome: 33. Lane T, Loeffler JM, Rowczenio DM, et al. AA amyloidosis complicating
beyond the case reports: review and follow-up of 94 patients with an the hereditary periodic fever syndromes. Arthritis Rheum
emphasis on prognosis and treatment. Semin Arthritis Rheum 2013;65:1116–21.
2007;37:137–48. 34. Yilmaz S, Cinar M, Simsek I, et al. Tocilizumab in the treatment of
20. de Koning HD, Schalkwijk J, van der Meer JW, et al. Successful patients with AA amyloidosis secondary to familial Mediterranean fever.
canakinumab treatment identifies IL-1beta as a pivotal mediator in Rheumatology 2015;54:564–5.
Schnitzler syndrome. J Allergy Clin Immunol 2011;128:1352–4.